Please provide your email address to receive an email when new articles are posted on . The platform combines canaloplasty with the placement of a scleral bio-implant. The company will use data from ...
WHITE PLAINS, N.Y., March 31, 2026 (GLOBE NEWSWIRE)-- Iantrek, Inc., a pioneer and leader in bio-interventional ophthalmic surgery (BIOS), today announced the introduction and US controlled release ...
Controlled early clinical adoption begins across select U.S. centers as Iantrek accelerates toward commercialization of its next-generation canal-based restoration technology WHITE PLAINS, N.Y., March ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results